{"meta":{"query_hash":"dc97dff233d3","filters":{"venue":"CPT Pharmacometrics & Systems Pharmacology"},"cohort_total":48,"direct_labels_cover":0,"predictions_cover":48,"exported":48,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/dc97dff233d3","api":"https://metacan.xera.ac/api/v1/cohort?venue=CPT+Pharmacometrics+%26+Systems+Pharmacology"},"results":[{"id":"W2023850571","doi":"10.1038/psp.2013.22","title":"Dose Response and Pharmacokinetics of Tofacitinib (CP‐690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis","year":2013,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Psoriasis; Pharmacokinetics; Clinical trial; Placebo; Population; Pharmacology; Plaque psoriasis; Internal medicine; Covariate; Dosing; Dermatology; Rheumatoid arthritis; Statistics; Pathology; Mathematics","score_opus":0.03613601634449804,"score_gpt":0.30933716649492865,"score_spread":0.2732011501504306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023850571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908067,0.0007314106,0.008714811,0.000114458184,0.000011118446,0.00011510248,0.0005388747,0.000079550446,0.0006138887],"genre_scores_gemma":[0.99696594,0.00021090131,0.0020022318,0.000046228728,0.000010803333,0.000078523655,0.000321614,0.00001722434,0.0003465297],"study_design_codex":"simulation_or_modeling","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99805874,0.0013895729,0.00004329561,0.00018326599,0.0002363733,0.00008874435],"domain_scores_gemma":[0.9977781,0.0013104009,0.0005060581,0.00023330822,0.000084266554,0.0000878398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054223463,0.00040055264,0.0007916926,0.00051062624,0.00011631907,0.0005716193,0.00031510598,0.00054739893,0.0009103709],"category_scores_gemma":[0.0061754645,0.0004911967,0.0013252049,0.0004937883,0.00027878984,0.00039357893,0.00023686572,0.0010068201,0.00023175534],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1387316,0.008428815,0.15986176,0.0007164248,0.0070262053,0.0005043833,0.0007958864,0.27305895,0.21241346,0.0024003165,0.002730873,0.19333138],"study_design_scores_gemma":[0.0061761867,0.05964742,0.21971393,0.00003977023,0.0034161645,0.0011313533,0.00013941858,0.6441302,0.059196368,0.0024512575,0.0037319195,0.0002259722],"about_ca_topic_score_codex":0.0012195552,"about_ca_topic_score_gemma":0.00084097666,"teacher_disagreement_score":0.0054223463,"about_ca_system_score_codex":0.0008857749,"about_ca_system_score_gemma":0.00068123796,"threshold_uncertainty_score":0.02867639},"labels":[],"label_agreement":null},{"id":"W2139500170","doi":"10.1038/psp.2014.45","title":"Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development","year":2014,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Physiologically based pharmacokinetic modelling; Computer science; Pharmacokinetics; Drug development; Modeling and simulation; Management science; Drug; Pharmacology; Medicine; Simulation; Engineering","score_opus":0.07256514769696606,"score_gpt":0.385557649965583,"score_spread":0.31299250226861697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139500170","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006628501,0.0103703225,0.9547305,0.0041058077,0.00032283977,0.000116743744,0.00033492604,0.0004737849,0.02291649],"genre_scores_gemma":[0.30876192,0.059742406,0.599973,0.001657943,0.0013047381,0.0013065797,0.00083475566,0.0006158005,0.02580278],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99889874,0.0006100234,0.00005581867,0.00009164441,0.0002972384,0.000046526246],"domain_scores_gemma":[0.9979511,0.0015178171,0.00015454442,0.000082774626,0.00021825019,0.000075500604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017536859,0.0007630424,0.0009856687,0.0006561599,0.00051991607,0.001820605,0.0011627787,0.0020058898,0.0035854196],"category_scores_gemma":[0.0052437144,0.00083004544,0.0010282446,0.0012172555,0.00093975355,0.0014997593,0.001333184,0.0027151583,0.0014178684],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025737583,0.000039036397,0.0008362743,0.00014821258,0.000034295954,0.00014917288,0.00010042921,0.83465856,0.00093034987,0.11923717,0.0058739083,0.03796676],"study_design_scores_gemma":[0.000012449392,0.000035714787,0.000290297,0.000076859964,0.000010474395,0.0000784153,0.00003066444,0.91451585,0.00052732916,0.05551776,0.02887878,0.000025453883],"about_ca_topic_score_codex":0.008974998,"about_ca_topic_score_gemma":0.0039318013,"teacher_disagreement_score":0.008974998,"about_ca_system_score_codex":0.0013569748,"about_ca_system_score_gemma":0.0022733838,"threshold_uncertainty_score":0.017845511},"labels":[],"label_agreement":null},{"id":"W2292177683","doi":"10.1002/psp4.12069","title":"Approaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through Reconstruction","year":2016,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical; Université de Montréal; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Mitacs; McGill University; Novartis; Pfizer","keywords":"Forensic engineering; Biology; Engineering","score_opus":0.05893023120036727,"score_gpt":0.37050854256729765,"score_spread":0.31157831136693037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292177683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38186622,0.057927884,0.32640937,0.11749005,0.0011142568,0.000338224,0.009128457,0.00092537416,0.10480017],"genre_scores_gemma":[0.91615814,0.01644032,0.05988805,0.0020169646,0.00052894716,0.00009460065,0.0022168858,0.000112539434,0.0025435367],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9953583,0.0030833713,0.00031271164,0.0004035724,0.00073429267,0.00010786761],"domain_scores_gemma":[0.9831041,0.010025293,0.0016641442,0.00303071,0.0017207549,0.00045499683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010690943,0.00056768215,0.0008849288,0.009517162,0.001207111,0.0048888675,0.0013863432,0.0010861766,0.0048813415],"category_scores_gemma":[0.048691843,0.0003790787,0.00055233494,0.009544868,0.0055487826,0.006009329,0.0025280758,0.0021095935,0.00093887653],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030035595,0.00015044495,0.1022763,0.0010730898,0.000548831,0.00032205702,0.003086184,0.014574571,0.0007123429,0.38943502,0.013976075,0.47354472],"study_design_scores_gemma":[0.000029265422,0.00012339534,0.05009809,0.0008633501,0.00024756728,0.0006032296,0.0037630368,0.03407352,0.0012205531,0.817305,0.09156897,0.00010409636],"about_ca_topic_score_codex":0.0069338693,"about_ca_topic_score_gemma":0.0047110766,"teacher_disagreement_score":0.010690943,"about_ca_system_score_codex":0.0024135376,"about_ca_system_score_gemma":0.0036427025,"threshold_uncertainty_score":0.056539774},"labels":[],"label_agreement":null},{"id":"W2601521858","doi":"10.1002/psp4.12182","title":"Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; Eli Lilly and Company; Galderma; Astellas Pharma; Mylan; UCB Pharma; Regeneron Pharmaceuticals; Genentech; Celgene; Sanofi; Amgen; Pfizer; Meiji Seika Pharma","keywords":"Tofacitinib; Janus kinase inhibitor; Plaque psoriasis; Medicine; Psoriasis; Potency; Body weight; Internal medicine; Psoriasis Area and Severity Index; Population; Pharmacology; Body surface area; Janus kinase; Clinical trial; Dermatology; Chemistry","score_opus":0.0632394518170323,"score_gpt":0.38185053162312693,"score_spread":0.3186110798060946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601521858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892292,0.0044116494,0.004568381,0.00012783079,0.000021714277,0.00032681983,0.00045505533,0.000025085967,0.00083426374],"genre_scores_gemma":[0.9972204,0.0004588766,0.0015477061,0.00007286515,0.000032328444,0.00008148145,0.0003605752,0.000012536766,0.00021323244],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9895796,0.0077666654,0.00062073994,0.0005150679,0.0012008293,0.00031708213],"domain_scores_gemma":[0.9835738,0.011361162,0.0036213167,0.0006943104,0.00041001468,0.00033932252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018298605,0.0006092437,0.0025176601,0.0009399645,0.00017039201,0.0010560302,0.0004968293,0.00061171886,0.00106527],"category_scores_gemma":[0.013787051,0.00037278427,0.0053314115,0.0009291906,0.000515731,0.0008488622,0.0006456326,0.00092652254,0.00015505968],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4052863,0.0032591405,0.31240538,0.0011451085,0.029371565,0.00027304367,0.00033423523,0.06416516,0.031638198,0.001073614,0.00065644726,0.15039171],"study_design_scores_gemma":[0.014152292,0.30960563,0.5566492,0.00012485607,0.019801024,0.00071678305,0.0002218273,0.07415532,0.01804658,0.00214485,0.004237011,0.00014462537],"about_ca_topic_score_codex":0.00053972163,"about_ca_topic_score_gemma":0.00071767916,"teacher_disagreement_score":0.018298605,"about_ca_system_score_codex":0.0010167166,"about_ca_system_score_gemma":0.001049479,"threshold_uncertainty_score":0.096773446},"labels":[],"label_agreement":null},{"id":"W2617283416","doi":"10.1002/psp4.12200","title":"A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; ViiV Healthcare","keywords":"Darunavir; Efavirenz; Drug; Emtricitabine; Medicine; Drug resistance; Population; Lymph node; HIV drug resistance; Human immunodeficiency virus (HIV); Intensive care medicine; Pharmacology; Oncology; Internal medicine; Antiretroviral therapy; Virology; Biology; Viral load; Genetics","score_opus":0.024856169110513134,"score_gpt":0.31447852652786945,"score_spread":0.2896223574173563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617283416","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13244571,0.0012766054,0.84822434,0.0021410724,0.00014608428,0.00016187476,0.0013332622,0.0003374117,0.013933733],"genre_scores_gemma":[0.94173044,0.0013202415,0.0404218,0.00034115766,0.0001363335,0.00051591906,0.0006907916,0.000088990564,0.014754401],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99971455,0.00011296001,0.00001632764,0.000050570277,0.000045237794,0.000060285514],"domain_scores_gemma":[0.9982017,0.0013448971,0.00018867895,0.000044292476,0.00016037443,0.000059872527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011290675,0.00080114364,0.0010679482,0.0008338411,0.0003986687,0.0010643831,0.0010176304,0.0014610522,0.0026707328],"category_scores_gemma":[0.0036657455,0.00043625827,0.0011657226,0.0007696457,0.0006598045,0.0010061959,0.00078169705,0.0010356935,0.0004410738],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013629276,0.000017440057,0.0007277555,0.000020206813,0.000014599825,0.000038566945,0.000014175665,0.99130577,0.0003208141,0.005640051,0.00026257703,0.0016243709],"study_design_scores_gemma":[0.00000432352,0.000007972278,0.00010176343,0.000002571963,0.0000048800716,0.000009628875,0.000002862795,0.99809724,0.00003979238,0.0015758986,0.00015015424,0.000002934418],"about_ca_topic_score_codex":0.010393385,"about_ca_topic_score_gemma":0.004145393,"teacher_disagreement_score":0.010393385,"about_ca_system_score_codex":0.0010149374,"about_ca_system_score_gemma":0.0013574518,"threshold_uncertainty_score":0.020665765},"labels":[],"label_agreement":null},{"id":"W2748594989","doi":"10.1002/psp4.12245","title":"Model‐Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Drug development; Process development; Biopharmaceutical; Drug discovery; Computational biology; Monoclonal antibody; Clinical efficacy; Medicine; Drug; Computer science; Pharmacology; Bioinformatics; Biology; Engineering; Immunology; Antibody; Internal medicine; Biotechnology; Process management","score_opus":0.07858451370996541,"score_gpt":0.3975746733348072,"score_spread":0.3189901596248418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748594989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7177255,0.030408978,0.14613537,0.0083764605,0.00031071005,0.0003061143,0.0007075486,0.00090079656,0.09512846],"genre_scores_gemma":[0.90255404,0.012306409,0.06875665,0.00033043674,0.000080989164,0.00012242733,0.00030436408,0.0000725625,0.015472082],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99975485,0.00011314193,0.000009028254,0.000020397258,0.00007312645,0.00002940919],"domain_scores_gemma":[0.9995839,0.00029772383,0.000019457664,0.000023264023,0.000040576888,0.00003508939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008382162,0.0004220721,0.00048680798,0.00021967274,0.00045061015,0.0012982665,0.0006397305,0.0013344054,0.0009957909],"category_scores_gemma":[0.0008076229,0.0001546026,0.0006000017,0.00040796923,0.00073474477,0.0005186956,0.0004786986,0.0010966564,0.00022194756],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040721655,0.0007996245,0.005363814,0.0009215312,0.00014476891,0.0023974476,0.0007502584,0.7537839,0.024060586,0.12012668,0.0109967515,0.0802474],"study_design_scores_gemma":[0.00016023753,0.0012495811,0.0032817929,0.0001782958,0.000119011886,0.00076550903,0.00054282666,0.86787784,0.023755869,0.021416994,0.080585465,0.000066544766],"about_ca_topic_score_codex":0.006085269,"about_ca_topic_score_gemma":0.0059201345,"teacher_disagreement_score":0.006085269,"about_ca_system_score_codex":0.0009448734,"about_ca_system_score_gemma":0.0006643976,"threshold_uncertainty_score":0.012099683},"labels":[],"label_agreement":null},{"id":"W2766248288","doi":"10.1002/psp4.12252","title":"Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Thrasher Research Fund","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Plasma concentration; Regimen; Confidence interval; Area under the curve; Minimum inhibitory concentration; Population; Pharmacology; Medicine; Chemistry; Internal medicine; Antibiotics","score_opus":0.06842512572379734,"score_gpt":0.3693630458961107,"score_spread":0.30093792017231336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766248288","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29083428,0.00090353086,0.6910235,0.00081228063,0.000085704574,0.00033132953,0.0027971333,0.000885274,0.012326864],"genre_scores_gemma":[0.9381439,0.000593162,0.051512606,0.00022268177,0.000033101212,0.00074728136,0.0013072597,0.000082422994,0.0073575657],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998579,0.000045076315,0.000009177087,0.00003724676,0.000032604148,0.000017927177],"domain_scores_gemma":[0.9996741,0.0001779345,0.00004471091,0.000012262326,0.00007348665,0.000017462253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003844064,0.00049899635,0.0006810514,0.0002208246,0.0002055918,0.00059176,0.0007708843,0.00096900703,0.0014036562],"category_scores_gemma":[0.0011338741,0.00038171106,0.00077568175,0.00022080753,0.00020685929,0.0003358062,0.0003856731,0.00081516354,0.0003561141],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006105854,0.000030396435,0.0017659117,0.000038496735,0.00003082727,0.000085969,0.000036139234,0.9902563,0.002661035,0.0012415976,0.0003053909,0.0034867604],"study_design_scores_gemma":[0.0000171059,0.00003306762,0.00043498894,0.0000037415798,0.000012414711,0.000027264181,0.0000054214447,0.99818075,0.00033541687,0.00038182683,0.0005624772,0.000005572636],"about_ca_topic_score_codex":0.013401774,"about_ca_topic_score_gemma":0.0064053233,"teacher_disagreement_score":0.013401774,"about_ca_system_score_codex":0.0005527863,"about_ca_system_score_gemma":0.0013646822,"threshold_uncertainty_score":0.026647568},"labels":[],"label_agreement":null},{"id":"W2882991814","doi":"10.1002/psp4.12338","title":"Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on<scp>ECMO</scp>","year":2018,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Blackberry (Canada)","funders":"National Center for Advancing Translational Sciences; National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; Biomedical Advanced Research and Development Authority; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Children's Hospital of Philadelphia; Thrasher Research Fund","keywords":"Life support; Dosing; Extracorporeal; Pharmacokinetics; Fluconazole; Extracorporeal membrane oxygenation; Medicine; Pharmacology; Intensive care medicine; Anesthesia; Antifungal; Internal medicine","score_opus":0.04443819642409358,"score_gpt":0.3241481951567232,"score_spread":0.27970999873262964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2882991814","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19409434,0.00094811426,0.795014,0.000800915,0.00006041569,0.00034636603,0.0008566447,0.000494432,0.007384725],"genre_scores_gemma":[0.9180634,0.0008640801,0.07791328,0.00030944726,0.000026215102,0.00039061636,0.00043126717,0.00006808972,0.0019335105],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99960786,0.00014960491,0.00003309258,0.000070610295,0.00011154066,0.000027310036],"domain_scores_gemma":[0.99957603,0.0002252566,0.000089549205,0.000023938077,0.000068993526,0.000016198303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052395667,0.00053243147,0.0005720483,0.00034392715,0.00021805342,0.00078521203,0.00079508376,0.00080449897,0.0010024322],"category_scores_gemma":[0.0020744374,0.00035630885,0.0006246846,0.00031123566,0.000233688,0.00045192323,0.00040561517,0.0010081476,0.00032653447],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017667486,0.00021548284,0.016235357,0.00017040294,0.00014399346,0.00039813947,0.00016422237,0.8901224,0.03585898,0.006282416,0.001437147,0.048794776],"study_design_scores_gemma":[0.000033234486,0.00018413164,0.0045267167,0.00001591181,0.000037687234,0.0001932425,0.00003767322,0.9837106,0.0076783993,0.0011181812,0.0024393038,0.00002487048],"about_ca_topic_score_codex":0.009240567,"about_ca_topic_score_gemma":0.0052233385,"teacher_disagreement_score":0.009240567,"about_ca_system_score_codex":0.0010095105,"about_ca_system_score_gemma":0.0020686984,"threshold_uncertainty_score":0.018373549},"labels":[],"label_agreement":null},{"id":"W2919263543","doi":"10.1002/psp4.12398","title":"Physiologically‐Based Pharmacokinetic Modeling Analysis for Quantitative Prediction of Renal Transporter–Mediated Interactions Between Metformin and Cimetidine","year":2019,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Cimetidine; Metformin; Pharmacokinetics; Pharmacology; Transporter; Chemistry; Drug; In vitro; Medicine; Insulin; Internal medicine; Biochemistry","score_opus":0.07485222278912905,"score_gpt":0.3512747445962903,"score_spread":0.27642252180716126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919263543","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15230438,0.0011187396,0.8340339,0.00074782735,0.000067631256,0.00025849915,0.00088615826,0.00091624237,0.009666656],"genre_scores_gemma":[0.9379828,0.000756888,0.05588184,0.00021179594,0.000044439363,0.0005878941,0.00055469846,0.00013332056,0.0038464195],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996817,0.00012036447,0.000018179806,0.000050790073,0.00009140208,0.00003750983],"domain_scores_gemma":[0.99900717,0.00071046996,0.000094895055,0.00003615935,0.00013177,0.000019615189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008789678,0.0008472165,0.0008529868,0.00051955786,0.0003113722,0.0009253791,0.0008773809,0.0012390002,0.0012688],"category_scores_gemma":[0.0024273423,0.0005020895,0.0013038974,0.000435056,0.00031779526,0.0006047215,0.00041481745,0.0012335753,0.000384306],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020851796,0.00002890695,0.00030604634,0.000026616166,0.000019411893,0.000038050086,0.000010856423,0.9931022,0.002071153,0.0017898327,0.00017664475,0.0024094114],"study_design_scores_gemma":[0.000001960154,0.0000075573153,0.00006830491,0.0000012869452,0.0000027972924,0.000005010118,0.0000013706752,0.99926883,0.00020429198,0.00029841583,0.00013740954,0.000002743044],"about_ca_topic_score_codex":0.013710083,"about_ca_topic_score_gemma":0.005573143,"teacher_disagreement_score":0.013710083,"about_ca_system_score_codex":0.0010962323,"about_ca_system_score_gemma":0.0016009482,"threshold_uncertainty_score":0.027260542},"labels":[],"label_agreement":null},{"id":"W2945839580","doi":"10.1002/psp4.12414","title":"Physiologically‐Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants","year":2019,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Pharmacokinetics; Cerebrospinal fluid; Dosing; Fluconazole; Medicine; Physiologically based pharmacokinetic modelling; Plasma concentration; Pharmacology; Internal medicine; Antifungal","score_opus":0.05298117718930536,"score_gpt":0.3324642961910152,"score_spread":0.27948311900170986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945839580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95895857,0.0002877966,0.038306702,0.0001642412,0.000009610764,0.00007671974,0.00048263095,0.00007761588,0.0016361767],"genre_scores_gemma":[0.9930581,0.00018297018,0.00586957,0.000028626997,0.0000026954367,0.00008000849,0.00029441577,0.000007412235,0.00047619003],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998375,0.00006737834,0.000010449919,0.000028912977,0.000039062368,0.00001662749],"domain_scores_gemma":[0.99959534,0.00026166535,0.000051655938,0.000013082669,0.000066757035,0.000011618591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036626312,0.0004058122,0.0004499708,0.00015743806,0.00021924757,0.0005219852,0.0004107726,0.00056740706,0.00035887977],"category_scores_gemma":[0.0014993037,0.00019628574,0.00045654541,0.00019786642,0.00020018271,0.00023088678,0.00022434213,0.0005065891,0.000080525126],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015751245,0.00005646101,0.006385189,0.00004876247,0.000034458273,0.00019364258,0.00006358127,0.9792819,0.008304108,0.0005173463,0.00015631336,0.0048007104],"study_design_scores_gemma":[0.000019369385,0.00016741389,0.0032830248,0.0000041416447,0.000015846324,0.00006814533,0.00002721339,0.9931773,0.0027033666,0.0002832481,0.00024046935,0.000010393215],"about_ca_topic_score_codex":0.019173136,"about_ca_topic_score_gemma":0.006642079,"teacher_disagreement_score":0.019173136,"about_ca_system_score_codex":0.00068146037,"about_ca_system_score_gemma":0.0011732723,"threshold_uncertainty_score":0.03812307},"labels":[],"label_agreement":null},{"id":"W2963315585","doi":"10.1002/psp4.12456","title":"Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients","year":2019,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Physiologically based pharmacokinetic modelling; Allometry; Pharmacokinetics; Population; Medicine; Pharmacology; Biology; Ecology","score_opus":0.07103963999053865,"score_gpt":0.36196636542348953,"score_spread":0.2909267254329509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963315585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7549741,0.00714841,0.22783358,0.0011214813,0.000114118295,0.00031499352,0.00133984,0.0012375162,0.005915836],"genre_scores_gemma":[0.9643631,0.0014744287,0.03305754,0.00009833316,0.000037864458,0.00008242075,0.000540637,0.000086363274,0.00025935497],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982445,0.0011174886,0.000108107364,0.0002211882,0.00026054835,0.000048327493],"domain_scores_gemma":[0.9965205,0.0018804052,0.00077326456,0.000391707,0.00034794118,0.00008620892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044746567,0.0006559486,0.0008746898,0.0011400344,0.00018345805,0.0013667953,0.00052420894,0.0004957826,0.00096006744],"category_scores_gemma":[0.011283514,0.00030231354,0.0009260067,0.0010233164,0.00032112474,0.00076435937,0.0006292825,0.0010199754,0.00044190456],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002102873,0.0003509846,0.29780352,0.00043595713,0.000861589,0.00043092863,0.00071098754,0.34274507,0.010826794,0.004430656,0.0031773732,0.33612332],"study_design_scores_gemma":[0.00011608697,0.0016108629,0.08962543,0.00012746414,0.0002829785,0.001114663,0.00023191446,0.8935723,0.0049960897,0.0035735369,0.0046687317,0.000079926685],"about_ca_topic_score_codex":0.0022730064,"about_ca_topic_score_gemma":0.0015575086,"teacher_disagreement_score":0.0044746567,"about_ca_system_score_codex":0.0006163163,"about_ca_system_score_gemma":0.00091773,"threshold_uncertainty_score":0.023664534},"labels":[],"label_agreement":null},{"id":"W2982361299","doi":"10.1002/psp4.12473","title":"Open Systems Pharmacology Community—An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences","year":2019,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Blackberry (Canada); University of Waterloo","funders":"Horizon 2020 Framework Programme","keywords":"Open science; Open source; Computer science; Pharmaceutical sciences; Management science; Medicine; Pharmacology; Engineering; Mathematics","score_opus":0.615142784337664,"score_gpt":0.6194145034598243,"score_spread":0.004271719122160289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982361299","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017151899,0.00493294,0.89866114,0.0104237,0.0021998577,0.0007529299,0.002429652,0.03200584,0.046878807],"genre_scores_gemma":[0.054422703,0.019623494,0.85680634,0.0055952976,0.0039522727,0.0037592608,0.010515073,0.021258805,0.024066787],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98654395,0.0040707625,0.0008732049,0.0012347832,0.006622034,0.0006552989],"domain_scores_gemma":[0.9727481,0.01156307,0.001591213,0.0065253326,0.0043906146,0.0031816326],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.01802039,0.002072407,0.0028571738,0.0038718544,0.002912134,0.011484485,0.009341806,0.008163581,0.03896843],"category_scores_gemma":[0.032658752,0.0016569037,0.003988073,0.004397993,0.0055522146,0.012041305,0.016674051,0.011380159,0.016618485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003040627,0.00047321303,0.001393504,0.0022204649,0.00038853605,0.00045551028,0.0010205734,0.043228474,0.0048935115,0.5348543,0.17296025,0.23780759],"study_design_scores_gemma":[0.0002631063,0.00014034516,0.0004175608,0.0009205039,0.000075282,0.00023606479,0.0001350996,0.08946889,0.002592144,0.28968537,0.61589825,0.00016749256],"about_ca_topic_score_codex":0.0028584648,"about_ca_topic_score_gemma":0.0018318021,"teacher_disagreement_score":0.99065816,"about_ca_system_score_codex":0.002365532,"about_ca_system_score_gemma":0.011024952,"threshold_uncertainty_score":0.13036233},"labels":[],"label_agreement":null},{"id":"W3119901445","doi":"10.1002/psp4.12577","title":"Model‐Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes","year":2021,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Physiologically based pharmacokinetic modelling; Dapagliflozin; Pharmacokinetics; Dosing; Pharmacology; Context (archaeology); Medicine; Drug; Internal medicine; Endocrinology; Biology","score_opus":0.056117851728890875,"score_gpt":0.3404270299676117,"score_spread":0.2843091782387208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119901445","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3373883,0.00071080244,0.64251715,0.000676556,0.000064544285,0.00018764916,0.0016130509,0.0006322264,0.01620973],"genre_scores_gemma":[0.9408104,0.0004506291,0.054937325,0.0001070396,0.00001796633,0.00019635358,0.00066982495,0.00012836144,0.0026819918],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998534,0.000055144563,0.0000064909445,0.000035585475,0.000029599722,0.000019912834],"domain_scores_gemma":[0.99958307,0.0002455715,0.00006164574,0.00001494504,0.00007348381,0.00002131635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047113554,0.00048127363,0.00042906753,0.0002833099,0.00022074184,0.00052842876,0.00069621444,0.0005055826,0.0017912894],"category_scores_gemma":[0.0017246372,0.00035756786,0.00057759,0.0001993621,0.00018745125,0.0003809716,0.00049976987,0.00069982954,0.00020375659],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033643704,0.00001567656,0.0019975675,0.000019953455,0.000012901275,0.000054386684,0.000021993828,0.9903859,0.0006667044,0.0019164106,0.00027077744,0.00460398],"study_design_scores_gemma":[0.0000049669507,0.000019715708,0.00028978378,0.0000037633222,0.000008723283,0.000014544484,0.000007910851,0.99826896,0.00032401548,0.0004485758,0.0006052442,0.0000038348144],"about_ca_topic_score_codex":0.014617139,"about_ca_topic_score_gemma":0.009130748,"teacher_disagreement_score":0.014617139,"about_ca_system_score_codex":0.0008266794,"about_ca_system_score_gemma":0.0014569582,"threshold_uncertainty_score":0.029064119},"labels":[],"label_agreement":null},{"id":"W3164065928","doi":"10.1002/psp4.12647","title":"Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy","year":2021,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Sanofi Genzyme; Grifols; Mitsubishi Tanabe Pharma Corporation; CSL Behring; Baxalta; Argenx; European Commission; TG Therapeutics; Sanofi","keywords":"Chronic inflammatory demyelinating polyneuropathy; Dosing; Medicine; Antibody; Placebo; Polyradiculoneuropathy; Immunoglobulin E; Immunology; Population; Internal medicine; Polyneuropathy; Pharmacodynamics; Pharmacokinetics; Immunoglobulin G; Gastroenterology; Guillain-Barre syndrome; Pathology","score_opus":0.03899096057079242,"score_gpt":0.38571714529331225,"score_spread":0.3467261847225198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164065928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96550083,0.00067958375,0.029927222,0.00039030387,0.0000124639855,0.0001767346,0.001549103,0.00020792754,0.0015558588],"genre_scores_gemma":[0.9974413,0.00008719978,0.0016353673,0.00003808016,0.0000073014967,0.00005017061,0.00057381095,0.000008934658,0.0001578835],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99651414,0.0025477628,0.00015202734,0.00031263704,0.00033741383,0.00013609718],"domain_scores_gemma":[0.9638848,0.031269707,0.0028241866,0.001230508,0.0005625818,0.00022827127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01097262,0.00057331193,0.0009363199,0.0019183899,0.00015718622,0.00092124316,0.0004184459,0.0007085199,0.0017041828],"category_scores_gemma":[0.026433557,0.0002395902,0.0015514675,0.0013955801,0.0005753126,0.0007494279,0.0005042679,0.00065792224,0.00021693009],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024144053,0.00045539913,0.27401176,0.00021820376,0.0018331149,0.00015289329,0.00010583259,0.68277645,0.0021339345,0.0020287472,0.00067747815,0.0331917],"study_design_scores_gemma":[0.00011523613,0.001432011,0.17450003,0.000025974496,0.00038771468,0.00022916502,0.000072178016,0.8160595,0.0011787924,0.005211153,0.0007472691,0.000040994928],"about_ca_topic_score_codex":0.0025596435,"about_ca_topic_score_gemma":0.0008187173,"teacher_disagreement_score":0.01097262,"about_ca_system_score_codex":0.0012786868,"about_ca_system_score_gemma":0.0007467997,"threshold_uncertainty_score":0.058029473},"labels":[],"label_agreement":null},{"id":"W3195626778","doi":"10.1002/psp4.12683","title":"Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study","year":2021,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation Charles-Bruneau; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Oak Foundation; National Science Foundation","keywords":"Medicine; Busulfan; Hematopoietic stem cell transplantation; Dosing; Pharmacokinetics; Population; Transplantation; Internal medicine; NONMEM; Oncology","score_opus":0.0286474273532771,"score_gpt":0.31781788589748167,"score_spread":0.2891704585442046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195626778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940553,0.00023877887,0.0052457964,0.000044135875,0.0000039343054,0.000031400737,0.00019225948,0.000046045214,0.000142309],"genre_scores_gemma":[0.99761343,0.0001219244,0.0018235081,0.000029917239,0.0000071447134,0.000018794753,0.00033473142,0.000012741859,0.000037792503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982673,0.00097347534,0.00006905673,0.00034207053,0.00030055692,0.000047507237],"domain_scores_gemma":[0.9964636,0.001673198,0.0008604412,0.0005281365,0.00039059154,0.00008405167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006295964,0.00046401663,0.0006759672,0.00016617436,0.00014951828,0.00057021267,0.00034909163,0.00033212235,0.00029022698],"category_scores_gemma":[0.0086924145,0.00017813368,0.0006171798,0.00031657328,0.00024507535,0.00032589844,0.00028719203,0.000520928,0.00008728798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009685899,0.0013227386,0.60471183,0.00019330336,0.002107619,0.0003763258,0.0012131963,0.21143381,0.024158482,0.0009141047,0.0022476027,0.14163503],"study_design_scores_gemma":[0.0015265108,0.019773733,0.6089616,0.000043105632,0.0016296832,0.00090903754,0.00027589052,0.33928445,0.021020344,0.0010297474,0.0054395976,0.000106379215],"about_ca_topic_score_codex":0.002448548,"about_ca_topic_score_gemma":0.0010334324,"teacher_disagreement_score":0.006295964,"about_ca_system_score_codex":0.00076087756,"about_ca_system_score_gemma":0.00090408616,"threshold_uncertainty_score":0.033296645},"labels":[],"label_agreement":null},{"id":"W4220832872","doi":"10.1002/psp4.12775","title":"Trapezoid bioequivalence: A rational bioavailability evaluation approach on account of the pharmaceutical‐driven balance of population average and variability","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada","keywords":"Bioequivalence; Context (archaeology); Bioavailability; Population; Econometrics; Statistics; Mathematics; Variance (accounting); Weighting; Pharmacology; Medicine; Economics; Accounting; Geography","score_opus":0.44227961583645825,"score_gpt":0.543427230074723,"score_spread":0.1011476142382648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220832872","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008255874,0.00025512613,0.98963225,0.00017728553,0.000019888304,0.00007609939,0.00003067843,0.00009105118,0.0014617998],"genre_scores_gemma":[0.43005607,0.0005003249,0.56562203,0.00032395936,0.000053955755,0.00042834925,0.00012879359,0.00016615803,0.0027204151],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974252,0.0015359618,0.00012568463,0.0002450353,0.0005383627,0.00012971585],"domain_scores_gemma":[0.9954508,0.0033438732,0.00029037817,0.0002316042,0.00057364756,0.00010967452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007004157,0.00086508907,0.002168575,0.0012118223,0.0004995529,0.0015328687,0.0016830186,0.0013209267,0.0028029254],"category_scores_gemma":[0.010636692,0.00073513313,0.001562295,0.0007886953,0.0010464939,0.0018704793,0.001518435,0.0016912741,0.00034387043],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011662404,0.000034749584,0.0006452146,0.00011401362,0.00010525578,0.00012024245,0.00010894082,0.92655325,0.0020699594,0.034222655,0.0007245924,0.035184607],"study_design_scores_gemma":[0.000012574751,0.00003347005,0.000067132554,0.000012732931,0.000013719636,0.000020815269,0.000008231338,0.9892413,0.00026645497,0.009908652,0.00040662306,0.0000082348715],"about_ca_topic_score_codex":0.004947547,"about_ca_topic_score_gemma":0.003458669,"teacher_disagreement_score":0.007004157,"about_ca_system_score_codex":0.0013609113,"about_ca_system_score_gemma":0.0027448053,"threshold_uncertainty_score":0.037041962},"labels":[],"label_agreement":null},{"id":"W4220836697","doi":"10.1002/psp4.12773","title":"Model‐based meta‐analysis of salbutamol pharmacokinetics and practical implications for doping control","year":2022,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmacological Effects and Assays","field":"Agricultural and Biological Sciences","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"World Anti-Doping Agency","funders":"World Anti-Doping Agency","keywords":"Salbutamol; Medicine; Urine; Inhalation; Anesthesia; Asthma; Pharmacokinetics; Dosing; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.33662412453639423,"score_gpt":0.4537262868446154,"score_spread":0.11710216230822118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220836697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08114696,0.81246185,0.086233556,0.0074017644,0.0019739685,0.000728886,0.0066297725,0.0008982169,0.0025248944],"genre_scores_gemma":[0.8915202,0.074558854,0.02405261,0.002365334,0.000644392,0.0010633057,0.003777159,0.00021504564,0.0018032461],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9822198,0.0149257295,0.0007870285,0.0013056231,0.0004867738,0.00027500466],"domain_scores_gemma":[0.9518056,0.044201065,0.0014072736,0.001474505,0.00084382604,0.00026773408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031331453,0.0023742183,0.007991075,0.0019733985,0.00049678545,0.0025756105,0.002482017,0.0022396445,0.0050366605],"category_scores_gemma":[0.04813326,0.0010800713,0.028920207,0.0023345228,0.0004454052,0.001199798,0.0009865124,0.0029078864,0.00042198645],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081810355,0.00017712962,0.031928696,0.038713012,0.77911824,0.00066713226,0.00015290861,0.09392684,0.00085983635,0.003539675,0.004819373,0.037916172],"study_design_scores_gemma":[0.0023575511,0.0013386359,0.016772846,0.0042053177,0.8409754,0.0003011286,0.00011842337,0.10611603,0.00060198567,0.014544023,0.012555657,0.00011294326],"about_ca_topic_score_codex":0.010065079,"about_ca_topic_score_gemma":0.00836066,"teacher_disagreement_score":0.031331453,"about_ca_system_score_codex":0.0013183043,"about_ca_system_score_gemma":0.002458233,"threshold_uncertainty_score":0.16569853},"labels":[],"label_agreement":null},{"id":"W4224228483","doi":"10.1002/psp4.12780","title":"Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Hemolysis; Medicine; Hemoglobin; Hemolytic anemia; Anemia; Sickle cell anemia; Drug; Internal medicine; Mechanism of action; Dosing; Pharmacology; Gastroenterology; Disease; Chemistry; Biochemistry","score_opus":0.03499161389658911,"score_gpt":0.3309906387624917,"score_spread":0.29599902486590257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224228483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7510851,0.012962754,0.20703493,0.0013173751,0.00016055128,0.0032933736,0.0077927243,0.0018036771,0.0145495925],"genre_scores_gemma":[0.9392735,0.005026341,0.048613098,0.00048039935,0.000033196873,0.0010967742,0.0030106504,0.00014070395,0.0023255409],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988925,0.00058309396,0.000043623975,0.00014870043,0.00023627449,0.000095868876],"domain_scores_gemma":[0.9986124,0.0005799641,0.00039916992,0.00016653532,0.00016212507,0.000079818456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035553256,0.0009386864,0.0016138087,0.0005954144,0.00018498853,0.001750791,0.00096002774,0.00090919936,0.0031218969],"category_scores_gemma":[0.0037015122,0.0005671951,0.0017020021,0.0005612396,0.0003485054,0.00079940265,0.0005542168,0.0011337331,0.0005575864],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024064222,0.0042640804,0.018848523,0.0031505814,0.0029397781,0.0004917569,0.00030213885,0.55853367,0.1879303,0.010208333,0.006528814,0.18273774],"study_design_scores_gemma":[0.0060054883,0.0583793,0.016672947,0.00028150794,0.0037267753,0.0011791474,0.00020367304,0.75799876,0.11118352,0.006395601,0.037660092,0.00031313056],"about_ca_topic_score_codex":0.0021943569,"about_ca_topic_score_gemma":0.0043990207,"teacher_disagreement_score":0.0035553256,"about_ca_system_score_codex":0.0014136073,"about_ca_system_score_gemma":0.0024416952,"threshold_uncertainty_score":0.018802583},"labels":[],"label_agreement":null},{"id":"W4225286977","doi":"10.1002/psp4.12793","title":"Use of <scp>physiologically‐based</scp> pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institutes of Health; National Institute of General Medical Sciences; American Foundation for Pharmaceutical Education","keywords":"Dosing; Methadone; Medicine; Fentanyl; Pharmacokinetics; Pharmacogenomics; Obesity; Opioid; Adverse effect; Pharmacology; Anesthesia; Internal medicine","score_opus":0.08443269079515993,"score_gpt":0.34989629578294806,"score_spread":0.26546360498778815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225286977","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30560338,0.0018264066,0.6477967,0.0037978597,0.0002873781,0.00030767827,0.004781949,0.0032485079,0.032350093],"genre_scores_gemma":[0.9203459,0.0012112927,0.07167787,0.0007968917,0.00006253574,0.00032214736,0.0016286827,0.00030202107,0.0036525582],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99973196,0.000112962305,0.000013163746,0.00004466934,0.000074284195,0.000023043967],"domain_scores_gemma":[0.9991691,0.00048773616,0.00012471317,0.00004807544,0.00013236736,0.00003800466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070732983,0.000589502,0.00046835575,0.00029671597,0.0003227573,0.0010008086,0.0007315682,0.0008031704,0.0025359495],"category_scores_gemma":[0.0027546003,0.0003676078,0.0009933752,0.0002688012,0.00031317188,0.0006391893,0.000612257,0.0009392546,0.000560749],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007909786,0.00005061114,0.007109357,0.0001037593,0.000077628945,0.00019825288,0.00006308024,0.9708925,0.0027553984,0.0043908637,0.002011748,0.01226777],"study_design_scores_gemma":[0.000022393722,0.000062531275,0.0010076998,0.00002483681,0.000025601912,0.000065198954,0.000019595438,0.9928523,0.00095700123,0.0020469856,0.0029003534,0.000015481148],"about_ca_topic_score_codex":0.023475427,"about_ca_topic_score_gemma":0.013516912,"teacher_disagreement_score":0.023475427,"about_ca_system_score_codex":0.0008139714,"about_ca_system_score_gemma":0.0017256095,"threshold_uncertainty_score":0.04667759},"labels":[],"label_agreement":null},{"id":"W4281786061","doi":"10.1002/psp4.12829","title":"Evaluation of covariate effects using forest plots and introduction to the <i>coveffectsplot</i> R package","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Forest ecology and management","field":"Environmental Science","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Covariate; R package; Computer science; Visualization; Statistics; Econometrics; Data mining; Mathematics; Machine learning","score_opus":0.03073177740404282,"score_gpt":0.30999481980871296,"score_spread":0.27926304240467015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281786061","genre_codex":"methods","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016850531,0.0015362261,0.8681066,0.0007130712,0.0005519107,0.00037623616,0.03727418,0.08451926,0.0052374946],"genre_scores_gemma":[0.020832982,0.0021026519,0.88847625,0.0010510782,0.0004546681,0.0038663694,0.026602903,0.050578155,0.006034885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936261,0.0036330547,0.0005746258,0.0007889785,0.0011294935,0.00024770683],"domain_scores_gemma":[0.9628316,0.02990489,0.0020105126,0.002609067,0.0023154942,0.0003283631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011344882,0.0029169843,0.0020236436,0.0038231143,0.00083888974,0.0026229823,0.0024774675,0.0012021221,0.101249315],"category_scores_gemma":[0.04635548,0.0015271235,0.0031158598,0.0039289636,0.0009892673,0.0025334635,0.0023576377,0.0042091855,0.032124035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005837945,0.00020829942,0.007191541,0.004458708,0.000683665,0.00059086736,0.00069572334,0.014999849,0.008599087,0.04132504,0.6274914,0.29317194],"study_design_scores_gemma":[0.0003172881,0.0003758576,0.009605826,0.0018726435,0.00030560824,0.0012601912,0.00022415463,0.056945298,0.014190807,0.08172983,0.83275336,0.0004191359],"about_ca_topic_score_codex":0.0029660703,"about_ca_topic_score_gemma":0.004117605,"teacher_disagreement_score":0.101249315,"about_ca_system_score_codex":0.00069891143,"about_ca_system_score_gemma":0.0018498931,"threshold_uncertainty_score":0.3387127},"labels":[],"label_agreement":null},{"id":"W4288050569","doi":"10.1002/psp4.12852","title":"Hallmarks of neurodegenerative disease: A systems pharmacology perspective","year":2022,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Neurodegeneration; Disease; Systems pharmacology; Neuroscience; Drug development; Huntington's disease; Identification (biology); Drug discovery; Medicine; Drug; Computational biology; Biology; Bioinformatics; Pharmacology; Pathology","score_opus":0.12867754276560453,"score_gpt":0.4523864801158535,"score_spread":0.32370893735024897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288050569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021167412,0.9914452,0.0030182207,0.0023653286,0.00032480276,0.000012871141,0.000033674805,0.000031288553,0.0025569105],"genre_scores_gemma":[0.0033955805,0.9932417,0.0015311205,0.0006360017,0.00047282275,0.000019254572,0.000033291293,0.0000042298857,0.00066587917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996393,0.00013911676,0.000035587116,0.000048406368,0.00011083837,0.000026715205],"domain_scores_gemma":[0.99914145,0.0005848744,0.0000671855,0.000034261408,0.00013583823,0.000036480888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00144633,0.0011778207,0.0018376145,0.0026715219,0.00026072082,0.0014748084,0.0012230538,0.001402087,0.0022461892],"category_scores_gemma":[0.0011077905,0.0003808874,0.00095748686,0.0025756361,0.0013947688,0.0021940344,0.00089055084,0.0033056275,0.0011141198],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009761303,0.00022494773,0.00047230299,0.029935693,0.0003501247,0.00038062176,0.00023091448,0.007067212,0.005323746,0.1548464,0.03540952,0.7656609],"study_design_scores_gemma":[0.000026806347,0.00031871948,0.0011428832,0.0053053848,0.00018548401,0.001256644,0.0001431741,0.0024384237,0.0018371729,0.09328735,0.8939909,0.00006712861],"about_ca_topic_score_codex":0.0017812838,"about_ca_topic_score_gemma":0.0021300744,"teacher_disagreement_score":0.0026715219,"about_ca_system_score_codex":0.0018462692,"about_ca_system_score_gemma":0.0017331296,"threshold_uncertainty_score":0.013395667},"labels":[],"label_agreement":null},{"id":"W4302283304","doi":"10.1002/psp4.12868","title":"Activity and perspective on quantitative modeling and simulation in Japan: Update from the Pharmaceuticals and Medical Devices Agency","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harmonization; Agency (philosophy); Drug development; Physiologically based pharmacokinetic modelling; Regulatory science; Medicine; Dosing; Risk analysis (engineering); Management science; Pharmacology; Drug; Business; Engineering; Pharmacokinetics","score_opus":0.22617426149743738,"score_gpt":0.5258151985447362,"score_spread":0.2996409370472989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302283304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006513523,0.8428515,0.038464796,0.059673473,0.011376249,0.00008651337,0.00095943076,0.00030870468,0.039765764],"genre_scores_gemma":[0.0408476,0.90751845,0.03150418,0.005712628,0.007031318,0.00013849222,0.0010540138,0.00026017416,0.005933201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973316,0.00065798144,0.00050593197,0.00023627588,0.0011310572,0.00013727557],"domain_scores_gemma":[0.985305,0.0043256213,0.0012280416,0.0007701851,0.0076230187,0.0007481606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0083227735,0.0011132297,0.0008467012,0.003916799,0.00070493383,0.0025845452,0.0017311564,0.001885339,0.0038037477],"category_scores_gemma":[0.011833629,0.00067288236,0.0014491216,0.005166383,0.0016339435,0.004176209,0.0020401564,0.003135496,0.0011233215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014927941,0.00015867694,0.0053539043,0.0061656362,0.00012855529,0.00043119944,0.0009073553,0.017849177,0.0024047876,0.09419557,0.16441798,0.7078379],"study_design_scores_gemma":[0.000012619059,0.000066982866,0.002263092,0.0020499337,0.000095186406,0.00029800457,0.00023423953,0.0072079566,0.0008550828,0.009009706,0.97784245,0.00006494803],"about_ca_topic_score_codex":0.019117076,"about_ca_topic_score_gemma":0.010056863,"teacher_disagreement_score":0.019117076,"about_ca_system_score_codex":0.0036732054,"about_ca_system_score_gemma":0.008722047,"threshold_uncertainty_score":0.044015586},"labels":[],"label_agreement":null},{"id":"W4310082281","doi":"10.1002/psp4.12886","title":"Delineating gene–environment effects using virtual twins of patients treated with clozapine","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Covariate; Clozapine; Statistics; Virtualization; Gene–environment interaction; Schizophrenia (object-oriented programming); Computer science; Econometrics; Psychology; Genotype; Mathematics; Biology; Psychiatry; Genetics","score_opus":0.017129206263323732,"score_gpt":0.2800405349078978,"score_spread":0.2629113286445741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310082281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922076,0.000015413672,0.0073216273,0.000029246135,0.000004376501,0.000015002765,0.00022145486,0.00003215541,0.00015321921],"genre_scores_gemma":[0.99471825,0.000014441867,0.004682647,0.0000138427495,0.0000017236578,0.000016329359,0.00041360373,0.0000102091935,0.00012900455],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994667,0.0003212596,0.000026427871,0.00010027087,0.000042304255,0.00004297414],"domain_scores_gemma":[0.99800974,0.0012380746,0.00021896187,0.000278908,0.00014595565,0.00010842077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015712715,0.0003739079,0.00050503516,0.000358418,0.00037900283,0.00051501923,0.00053306855,0.0004184924,0.0013794111],"category_scores_gemma":[0.0049031456,0.00046104274,0.0011754065,0.00027674568,0.00043218982,0.00028789713,0.0006590604,0.0005144123,0.00013581845],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026294969,0.00041293766,0.40733227,0.00006182946,0.0009471724,0.0007302406,0.00036143363,0.5491183,0.013593249,0.0031440868,0.00059702044,0.021071926],"study_design_scores_gemma":[0.00010707326,0.0005039542,0.06030299,0.000007973741,0.00021448878,0.0003777889,0.00015696329,0.9304241,0.0051390612,0.0021288334,0.00060016365,0.000036644204],"about_ca_topic_score_codex":0.021576805,"about_ca_topic_score_gemma":0.014733306,"teacher_disagreement_score":0.021576805,"about_ca_system_score_codex":0.000760066,"about_ca_system_score_gemma":0.00089617603,"threshold_uncertainty_score":0.04290241},"labels":[],"label_agreement":null},{"id":"W4311934119","doi":"10.1002/psp4.12907","title":"Regulatory utility of physiologically‐based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report","year":2022,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Bioequivalence; Session (web analytics); Regulatory science; Computer science; Food and drug administration; Management science; Pharmaceutical industry; Risk analysis (engineering); Medicine; Pharmacology; Pharmacokinetics; Engineering","score_opus":0.801231966031526,"score_gpt":0.6141261854069908,"score_spread":0.1871057806245352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311934119","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03406868,0.04461545,0.28302285,0.305661,0.035325523,0.0041229064,0.0020397909,0.0013667938,0.28977713],"genre_scores_gemma":[0.40620023,0.077769265,0.22356033,0.048333336,0.023170559,0.0064726737,0.004675273,0.0021397898,0.20767862],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9783054,0.010989746,0.0010556098,0.0015179616,0.0066353837,0.001495903],"domain_scores_gemma":[0.97132593,0.011045312,0.0018331531,0.002064962,0.0121423025,0.0015882322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07196847,0.0017576847,0.0008428973,0.0011692474,0.0015244822,0.009371956,0.0051049013,0.007161198,0.013586132],"category_scores_gemma":[0.028730748,0.0008060157,0.0025412743,0.00092735887,0.0013565343,0.0062978645,0.0055777538,0.008436392,0.0045478987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081472745,0.0016183611,0.001369016,0.0027735834,0.00030212238,0.0013338963,0.0036095919,0.03504426,0.016526755,0.13846487,0.44169906,0.35644376],"study_design_scores_gemma":[0.00021669774,0.0010687313,0.0011793489,0.0026602359,0.00011742424,0.00027972923,0.0017936695,0.013805012,0.008856648,0.032316096,0.93749774,0.00020851387],"about_ca_topic_score_codex":0.0027957482,"about_ca_topic_score_gemma":0.0027473753,"teacher_disagreement_score":0.07196847,"about_ca_system_score_codex":0.0045521706,"about_ca_system_score_gemma":0.012259808,"threshold_uncertainty_score":0.38061023},"labels":[],"label_agreement":null},{"id":"W4312039560","doi":"10.1002/psp4.12908","title":"Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of General Medical Sciences; University of Waterloo","keywords":"Physiologically based pharmacokinetic modelling; Cannabidiol; Pharmacokinetics; Pharmacology; Chemistry; Fluconazole; Itraconazole; CYP3A4; Cytochrome P450; Rifampicin; UGT2B7; In vitro; Enzyme; Medicine; Glucuronidation; Antifungal; Biochemistry; Microsome; Dermatology","score_opus":0.054367380134750794,"score_gpt":0.3995164767172026,"score_spread":0.3451490965824518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312039560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73148274,0.0018210057,0.25696477,0.00039695014,0.000055566325,0.00024701067,0.0043575014,0.0005478515,0.004126599],"genre_scores_gemma":[0.9707163,0.0008487813,0.025177082,0.00013710718,0.000008437231,0.00018642076,0.0017151143,0.000054991007,0.0011557585],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99962234,0.00016946431,0.000022225215,0.000088302026,0.00007573978,0.00002183341],"domain_scores_gemma":[0.9993543,0.00039820635,0.00007159861,0.00006222969,0.0000996671,0.000013937326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009800018,0.00054384535,0.0005754908,0.00025575366,0.00018846507,0.00095039036,0.00040639832,0.00069064583,0.0009598251],"category_scores_gemma":[0.0022074329,0.00027982335,0.0009363096,0.00030820462,0.0002331592,0.00028234077,0.00027438454,0.0007417939,0.0004947923],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084782136,0.00038207142,0.012991431,0.0004548947,0.00025097033,0.00033050013,0.000101871956,0.8839858,0.069932826,0.0019019749,0.0015735838,0.027246248],"study_design_scores_gemma":[0.0000651482,0.00067129394,0.0046391496,0.000037350717,0.0001412624,0.00026594652,0.00005202257,0.9227306,0.06636869,0.0010066357,0.0039799586,0.000041891064],"about_ca_topic_score_codex":0.01078123,"about_ca_topic_score_gemma":0.005155048,"teacher_disagreement_score":0.01078123,"about_ca_system_score_codex":0.0008851181,"about_ca_system_score_gemma":0.001341492,"threshold_uncertainty_score":0.02143693},"labels":[],"label_agreement":null},{"id":"W4318455086","doi":"10.1002/psp4.12931","title":"Establishing the suitability of <scp>model‐integrated</scp> evidence to demonstrate bioequivalence for <scp>long‐acting</scp> injectable and implantable drug products: Summary of workshop","year":2023,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"U.S. Food and Drug Administration; Teva Pharmaceutical Industries","keywords":"Bioequivalence; Food and drug administration; Computer science; Management science; Medicine; Risk analysis (engineering); Engineering; Pharmacology; Pharmacokinetics","score_opus":0.6228652721554956,"score_gpt":0.5726171040619016,"score_spread":0.050248168093594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318455086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013044081,0.9509676,0.021070829,0.01596549,0.0011025993,0.0007881504,0.00025974272,0.00006128119,0.008479992],"genre_scores_gemma":[0.025509326,0.9352284,0.030160373,0.005593111,0.0008475016,0.0009150107,0.00028346735,0.00003647794,0.0014263778],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9797403,0.012585068,0.0022817669,0.00069384655,0.0044151735,0.0002837785],"domain_scores_gemma":[0.91424984,0.0713665,0.004171987,0.0016352218,0.008161572,0.0004148167],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06545961,0.0010085367,0.0033115032,0.0036770098,0.00027545553,0.0035454808,0.0016593649,0.002271549,0.0025714673],"category_scores_gemma":[0.066339746,0.0007245664,0.0035709739,0.002548133,0.0012983518,0.0036545089,0.0016612825,0.0041299593,0.0007885495],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003671255,0.00012595292,0.0004574335,0.0753246,0.0016556619,0.00012444577,0.0002509131,0.0045194305,0.0018360933,0.055899933,0.015232327,0.84420604],"study_design_scores_gemma":[0.0006140211,0.0022491466,0.0034912638,0.20304482,0.0048252763,0.0007738775,0.00046922668,0.009213273,0.008423496,0.06959505,0.69706464,0.00023581724],"about_ca_topic_score_codex":0.0024950563,"about_ca_topic_score_gemma":0.003307851,"teacher_disagreement_score":0.9345404,"about_ca_system_score_codex":0.0033571208,"about_ca_system_score_gemma":0.013666802,"threshold_uncertainty_score":0.34618765},"labels":[],"label_agreement":null},{"id":"W4380422510","doi":"10.1002/psp4.12980","title":"Model‐based meta‐analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism","year":2023,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ethnic group; Mechanism (biology); Medicine; Drug; Markov chain Monte Carlo; Pharmacology; Statistics; Monte Carlo method","score_opus":0.4743222873254233,"score_gpt":0.5033028148323203,"score_spread":0.028980527506897003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380422510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016731845,0.96447986,0.015650937,0.0007809608,0.00040052665,0.0002041087,0.0011817627,0.00013696037,0.00043297923],"genre_scores_gemma":[0.65115696,0.3259391,0.015763318,0.0016833658,0.00059374113,0.00093688775,0.0029866316,0.0001544965,0.00078557205],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.985858,0.01040259,0.0013898914,0.0013660959,0.0008075596,0.0001758013],"domain_scores_gemma":[0.9734234,0.023060756,0.0014076605,0.001318881,0.0006608114,0.00012832876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027462177,0.0025649983,0.008155524,0.0034814337,0.00040943513,0.0021728396,0.0017310295,0.0013394641,0.0018791426],"category_scores_gemma":[0.03714403,0.0008094357,0.02756053,0.004391942,0.0003798847,0.0013061514,0.00090972095,0.0018201016,0.00022805462],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023396164,0.000032154312,0.021625217,0.028878056,0.9091127,0.00017599537,0.00004477786,0.0064980113,0.00042938173,0.0006098844,0.0009445127,0.029309738],"study_design_scores_gemma":[0.00044418755,0.00024039234,0.0115130395,0.0017575409,0.97385806,0.00019820525,0.00003411977,0.0059042037,0.00038431957,0.0024145797,0.0032182105,0.000033084238],"about_ca_topic_score_codex":0.0034187378,"about_ca_topic_score_gemma":0.005000536,"teacher_disagreement_score":0.027462177,"about_ca_system_score_codex":0.0010651626,"about_ca_system_score_gemma":0.001610266,"threshold_uncertainty_score":0.1452356},"labels":[],"label_agreement":null},{"id":"W4385514007","doi":"10.1002/psp4.13022","title":"<scp>SARS‐CoV</scp>‐2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy","year":2023,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council","keywords":"Viral load; Viral replication; Clinical trial; Medicine; Monoclonal antibody; Immunology; Virology; Selection (genetic algorithm); Virus; Antibody; Computer science; Internal medicine; Artificial intelligence","score_opus":0.0988031557012112,"score_gpt":0.42769283617812526,"score_spread":0.328889680476914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385514007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5042515,0.0010020661,0.47969544,0.0020415122,0.00014400914,0.00030644465,0.0022080413,0.00086561945,0.009485417],"genre_scores_gemma":[0.9695413,0.00028343615,0.027297944,0.000112995425,0.000044672044,0.00018959679,0.00077213574,0.000045609933,0.0017122617],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99939287,0.00040200006,0.000029637427,0.00006673664,0.000064567685,0.000044180062],"domain_scores_gemma":[0.99674135,0.0025206371,0.00030425962,0.00013938459,0.00023839083,0.000055937926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021388524,0.0006048293,0.000704011,0.00054335827,0.00023150908,0.0008652345,0.00055400026,0.00058416615,0.0017178883],"category_scores_gemma":[0.006215517,0.0003354544,0.0009975828,0.00040924526,0.00024625327,0.00044391508,0.00046068427,0.0006901507,0.00026053644],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057254794,0.000028120892,0.002370778,0.000022282253,0.00004461454,0.000030863055,0.000012521665,0.9910874,0.00042051266,0.0015019509,0.000293991,0.0041296957],"study_design_scores_gemma":[0.00001150804,0.000029243476,0.00059312576,0.0000043279583,0.000009651607,0.000008209788,0.000004209444,0.9976507,0.0002151937,0.00109203,0.00037795378,0.0000039190713],"about_ca_topic_score_codex":0.011291491,"about_ca_topic_score_gemma":0.0068683885,"teacher_disagreement_score":0.011291491,"about_ca_system_score_codex":0.00095986755,"about_ca_system_score_gemma":0.0014445158,"threshold_uncertainty_score":0.02245158},"labels":[],"label_agreement":null},{"id":"W4390405127","doi":"10.1002/psp4.13102","title":"Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling","year":2023,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; University of Utah; Brigham Young University","keywords":"Physiologically based pharmacokinetic modelling; Ontogeny; Pharmacokinetics; Furosemide; Biology; Transporter; Meropenem; Pharmacology; Internal medicine; Medicine; Endocrinology; Gene","score_opus":0.04037110607239169,"score_gpt":0.3314192358834291,"score_spread":0.2910481298110374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390405127","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1442353,0.00063756,0.8512365,0.00028728475,0.000014818222,0.00010065105,0.0011321802,0.0007875326,0.0015681528],"genre_scores_gemma":[0.7804237,0.0006622911,0.21178839,0.00017170078,0.000026624104,0.00043582032,0.0028388675,0.000338995,0.0033136513],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999506,0.00025923847,0.000027216776,0.00010945143,0.000065169465,0.00003294493],"domain_scores_gemma":[0.9976617,0.001787006,0.00022029174,0.00009511014,0.00019362911,0.000042284555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024686968,0.00073274004,0.0008591016,0.00058061973,0.00036944787,0.00097491615,0.00080456794,0.00082469825,0.001833408],"category_scores_gemma":[0.007665226,0.0006722875,0.0012284232,0.000509007,0.0003916826,0.000708472,0.000679599,0.0014564791,0.00057420187],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002188978,0.000051235795,0.011343388,0.000081930564,0.00011082245,0.00015202716,0.000098983895,0.9518591,0.0032128536,0.0040611406,0.0008464963,0.02796304],"study_design_scores_gemma":[0.000009932405,0.000021658812,0.0014889498,0.000008872566,0.000010976403,0.000041046715,0.000011840622,0.9951546,0.0006409462,0.00201677,0.00058457133,0.000009739032],"about_ca_topic_score_codex":0.007601944,"about_ca_topic_score_gemma":0.004757491,"teacher_disagreement_score":0.007601944,"about_ca_system_score_codex":0.0009157481,"about_ca_system_score_gemma":0.0013916927,"threshold_uncertainty_score":0.01511538},"labels":[],"label_agreement":null},{"id":"W4391053062","doi":"10.1002/psp4.13093","title":"Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Microfluidic and Capillary Electrophoresis Applications","field":"Engineering","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of British Columbia; Hotchkiss Brain Institute; BC Mental Health & Substance Use Services","funders":"Monash University","keywords":"Clozapine; Dosing; Schizophrenia (object-oriented programming); Pharmacokinetics; Fluvoxamine; Virtual patient; Virtualization; Drug; Medicine; Anesthesia; Pharmacology; Computer science; Internal medicine; Psychiatry; Fluoxetine","score_opus":0.01410371169017295,"score_gpt":0.2716500253713405,"score_spread":0.25754631368116754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391053062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6434649,0.00066618994,0.34936982,0.00084148475,0.00007941889,0.00015670044,0.00091405085,0.0022615297,0.002245855],"genre_scores_gemma":[0.9696833,0.0000863561,0.029627139,0.000090220085,0.000009045067,0.00003992542,0.00021549172,0.00003508886,0.0002134871],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994611,0.0003234081,0.000032884123,0.00007182937,0.00007822983,0.000032445456],"domain_scores_gemma":[0.9988815,0.00062858796,0.0001914748,0.00011129997,0.00011642188,0.000070614115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013227673,0.00046701208,0.0006722477,0.00047635785,0.0002210464,0.00087708,0.0004720593,0.00040758596,0.0008818898],"category_scores_gemma":[0.004952439,0.000386469,0.0006259773,0.00023943561,0.00022816096,0.0003510602,0.0008586654,0.00060378824,0.00018669745],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041387794,0.000354981,0.081197,0.00016221432,0.0006291625,0.000517363,0.00025851093,0.7560853,0.016068464,0.0042189527,0.002860821,0.13350849],"study_design_scores_gemma":[0.000048579866,0.000203999,0.0032886288,0.000009308459,0.00004316837,0.00009700941,0.000023205252,0.9904266,0.0037286626,0.0015789521,0.0005294802,0.000022465574],"about_ca_topic_score_codex":0.0069025108,"about_ca_topic_score_gemma":0.0063854973,"teacher_disagreement_score":0.0069025108,"about_ca_system_score_codex":0.00081445585,"about_ca_system_score_gemma":0.001399617,"threshold_uncertainty_score":0.013724685},"labels":[],"label_agreement":null},{"id":"W4394853075","doi":"10.1002/psp4.13141","title":"Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated <scp>DLBCL</scp> from the <scp>POLARIX</scp> study","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Rituximab; Adverse effect; Pharmacokinetics; Oncology; Population; Cyclophosphamide; Dosing; Pharmacology; Gastroenterology; Lymphoma; Chemotherapy","score_opus":0.026281336400886365,"score_gpt":0.3321197062955578,"score_spread":0.30583836989467145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394853075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824417,0.00026761513,0.00048345083,0.000044620563,0.0000045768998,0.00006680726,0.0004658171,0.000023863291,0.00039911733],"genre_scores_gemma":[0.99830484,0.00008429335,0.00023502138,0.000088682136,0.000013690626,0.000049980845,0.0010070954,0.000012180086,0.00020423257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901974,0.00044747975,0.0000477743,0.00020439636,0.00019171985,0.00008891253],"domain_scores_gemma":[0.99830437,0.000779106,0.00036976818,0.00023230465,0.000112549555,0.00020190775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021740743,0.0004036514,0.0008770524,0.00031099276,0.00018585131,0.0008381144,0.00030796407,0.00058128085,0.0009317389],"category_scores_gemma":[0.0024432985,0.000336659,0.0009940753,0.00039759194,0.00033573512,0.00056701136,0.00027545504,0.0012410359,0.00022489959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24185368,0.0062470934,0.55733776,0.0003266166,0.0051178015,0.0014484619,0.0008469181,0.023719402,0.08071326,0.0005500783,0.002843268,0.07899568],"study_design_scores_gemma":[0.018126108,0.09335503,0.8326792,0.000029226578,0.00251161,0.0021071895,0.0002774795,0.031535544,0.011990996,0.0012235207,0.006041781,0.00012234431],"about_ca_topic_score_codex":0.0007598736,"about_ca_topic_score_gemma":0.00070906134,"teacher_disagreement_score":0.0021740743,"about_ca_system_score_codex":0.00078593136,"about_ca_system_score_gemma":0.0004539354,"threshold_uncertainty_score":0.011497796},"labels":[],"label_agreement":null},{"id":"W4398254453","doi":"10.1002/psp4.13157","title":"Moving the needle for oncology dose optimization: A call for action","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Merck KGaA","keywords":"Call to action; Action (physics); Medical physics; Medicine; Business; Physics","score_opus":0.050752178952854936,"score_gpt":0.416172120841646,"score_spread":0.36541994188879107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398254453","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038404771,0.017291844,0.010378471,0.95830005,0.010182072,0.000055505472,0.0000701368,0.00022281139,0.003115157],"genre_scores_gemma":[0.020833595,0.036746737,0.08233461,0.8203776,0.030673647,0.00045797537,0.0003082993,0.000779185,0.0074884263],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9529002,0.019353617,0.0033213818,0.0037774502,0.018461768,0.002185669],"domain_scores_gemma":[0.8416805,0.09824961,0.006492441,0.009897035,0.027604481,0.01607592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08894874,0.0017271339,0.0027170302,0.0025426538,0.0054264595,0.018177312,0.0067545166,0.036851414,0.021582704],"category_scores_gemma":[0.1214936,0.0012299318,0.003117328,0.0023938834,0.016675904,0.03311705,0.012274916,0.06706341,0.0092966],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023940319,0.00035101286,0.0006764553,0.0009632737,0.000080046295,0.00030669436,0.0011551736,0.0016107257,0.0010831798,0.1253962,0.6737112,0.19442663],"study_design_scores_gemma":[0.000101896825,0.00024761484,0.00047055318,0.0016538865,0.000036872505,0.0003935746,0.0013050545,0.0011123217,0.00058157067,0.14551118,0.8484572,0.00012835594],"about_ca_topic_score_codex":0.0029210977,"about_ca_topic_score_gemma":0.0040107486,"teacher_disagreement_score":0.08894874,"about_ca_system_score_codex":0.008024005,"about_ca_system_score_gemma":0.034030903,"threshold_uncertainty_score":0.47041154},"labels":[],"label_agreement":null},{"id":"W4399355745","doi":"10.1002/psp4.13167","title":"Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of <scp>CYP2C19</scp> genetic variation and obesity in the pediatric population","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Duke Clinical Research Institute; National Institute of Environmental Health Sciences; University of North Carolina at Chapel Hill; Pennsylvania State University; University of Louisville; University of Pennsylvania; Wichita Medical Research and Education Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Penn State College of Medicine; Children's Hospital of Philadelphia","keywords":"Dosing; Physiologically based pharmacokinetic modelling; CYP2C19; Pharmacokinetics; Medicine; Pantoprazole; Population; Obesity; Pharmacology; Pharmacodynamics; Internal medicine; Omeprazole; Environmental health; Metabolism","score_opus":0.029294055198621893,"score_gpt":0.3344661254760887,"score_spread":0.30517207027746684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399355745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6497429,0.0039051196,0.31914425,0.0016960534,0.00015170916,0.00045585228,0.00359787,0.00055974134,0.020746402],"genre_scores_gemma":[0.9711822,0.0016043842,0.021021731,0.0003328661,0.00002999128,0.00036535412,0.00097125984,0.000066525565,0.0044257017],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997911,0.00007424517,0.000011133021,0.000044882938,0.000052546784,0.00002614867],"domain_scores_gemma":[0.99954575,0.0002650201,0.00007931995,0.000015200249,0.0000770446,0.000017535334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045471257,0.00056396984,0.0006727605,0.00025224852,0.0001725816,0.0006997809,0.0006277134,0.0008280598,0.0011892584],"category_scores_gemma":[0.0016833929,0.0003340919,0.0010710607,0.00028912973,0.00022105398,0.00036802347,0.00033137243,0.0007830704,0.00032136668],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018014874,0.0000942128,0.0064109536,0.00012459868,0.000110385685,0.0002413258,0.0000685414,0.975545,0.0061417534,0.0025277117,0.000981956,0.0075733312],"study_design_scores_gemma":[0.000035416513,0.000130252,0.0019294383,0.000013254293,0.00005161256,0.00011009377,0.000015315421,0.9946554,0.00065638294,0.0006128883,0.0017763609,0.000013676542],"about_ca_topic_score_codex":0.015247813,"about_ca_topic_score_gemma":0.0062726126,"teacher_disagreement_score":0.015247813,"about_ca_system_score_codex":0.0006878191,"about_ca_system_score_gemma":0.0012789785,"threshold_uncertainty_score":0.030318141},"labels":[],"label_agreement":null},{"id":"W4401818898","doi":"10.1002/psp4.13216","title":"Development and comparison of model‐integrated evidence approaches for bioequivalence studies with pharmacokinetic end points","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hamilton Health Sciences Foundation","keywords":"Bioequivalence; Resampling; Type I and type II errors; Nonparametric statistics; Statistics; Sample size determination; Computer science; Sampling (signal processing); Confidence interval; Mathematics; Bioavailability","score_opus":0.8675392696483202,"score_gpt":0.634633286820038,"score_spread":0.23290598282828223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401818898","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018384114,0.004014539,0.9927078,0.00019060829,0.000035177007,0.00041219205,0.00007880467,0.000101171565,0.00062137254],"genre_scores_gemma":[0.0590092,0.003659634,0.93390256,0.00024060416,0.000070757866,0.0024479679,0.00024825952,0.000064395856,0.00035665085],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.92327267,0.05971035,0.0044789515,0.0025808995,0.009567018,0.00039015285],"domain_scores_gemma":[0.8158245,0.16433036,0.00605447,0.004610784,0.008550271,0.0006296616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08314448,0.0020731883,0.0043935627,0.007397375,0.0004513352,0.004118303,0.0033711833,0.0027690479,0.0028904933],"category_scores_gemma":[0.19523707,0.0016773439,0.0066737537,0.0030229965,0.0014724229,0.004230985,0.0039781793,0.0046730493,0.00033854588],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010183873,0.0005051501,0.0029254297,0.006340733,0.008073554,0.0002253761,0.000511095,0.3194136,0.0019575332,0.19651593,0.0015694489,0.46094373],"study_design_scores_gemma":[0.00042174087,0.0012144694,0.0016815257,0.0017871236,0.0020157602,0.00020642288,0.000095777556,0.8635784,0.0019368285,0.118246056,0.008668073,0.00014784785],"about_ca_topic_score_codex":0.0018114934,"about_ca_topic_score_gemma":0.0017758734,"teacher_disagreement_score":0.08314448,"about_ca_system_score_codex":0.003157767,"about_ca_system_score_gemma":0.0056214808,"threshold_uncertainty_score":0.43971527},"labels":[],"label_agreement":null},{"id":"W4402014457","doi":"10.1002/psp4.13217","title":"Evaluation of model‐integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methods","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hamilton Health Sciences Foundation","keywords":"Bioequivalence; Pharmacokinetics; Econometrics; Computer science; Medicine; Mathematics; Pharmacology","score_opus":0.9654321675280938,"score_gpt":0.7370173842571133,"score_spread":0.22841478327098053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402014457","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011114787,0.0024190363,0.98349285,0.000342019,0.000058125814,0.0010390284,0.00018384648,0.0002230812,0.0011272762],"genre_scores_gemma":[0.30694687,0.0019258305,0.68625355,0.00029843822,0.00009187482,0.0036504199,0.0003844327,0.000089599715,0.0003590557],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.84380865,0.13269015,0.0069658277,0.0031243584,0.012921744,0.0004892584],"domain_scores_gemma":[0.5970994,0.36614457,0.013104228,0.01312781,0.009903403,0.00062059617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15824026,0.0021630207,0.0040388466,0.0058073867,0.0004905283,0.0032134005,0.0023335146,0.0019316862,0.0031236156],"category_scores_gemma":[0.3480014,0.0011308516,0.004899518,0.0033311252,0.001237579,0.0035668486,0.003217218,0.0027039868,0.00026845213],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023261542,0.00068295014,0.010159362,0.006058956,0.017059896,0.00023985344,0.00053269,0.3582341,0.0029785081,0.09321358,0.0015998001,0.50691414],"study_design_scores_gemma":[0.0007349218,0.0035978425,0.0048796446,0.0012724895,0.0042692544,0.00025955087,0.00013207435,0.8675893,0.003750608,0.10831864,0.0050537204,0.00014197656],"about_ca_topic_score_codex":0.0011965362,"about_ca_topic_score_gemma":0.0012755923,"teacher_disagreement_score":0.15824026,"about_ca_system_score_codex":0.002156134,"about_ca_system_score_gemma":0.00456111,"threshold_uncertainty_score":0.8368645},"labels":[],"label_agreement":null},{"id":"W4402647866","doi":"10.1002/psp4.13235","title":"Mathematical model of the relationship between pH holding time and erosive esophagitis healing rates","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Esophagitis; Gastric acid; Medicine; Gastroenterology; Reflux esophagitis; Internal medicine; Stomach; Reflux; Disease","score_opus":0.08904044853055816,"score_gpt":0.38189005289012495,"score_spread":0.2928496043595668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402647866","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23798102,0.00888664,0.6919023,0.013347665,0.00054665183,0.0012040846,0.01435141,0.0012945291,0.030485746],"genre_scores_gemma":[0.8663093,0.00473604,0.054283902,0.0019107211,0.00030407452,0.004418705,0.004952823,0.00024349288,0.06284103],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972874,0.0012099182,0.0001663494,0.0006436711,0.0002652826,0.00042750302],"domain_scores_gemma":[0.9759125,0.019742569,0.0024766766,0.0003496143,0.001100033,0.0004184842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077875517,0.0020984774,0.0026993759,0.0026809436,0.00056337425,0.0027465536,0.003037802,0.0033385297,0.016624361],"category_scores_gemma":[0.026357934,0.0014552557,0.0039877133,0.0014001415,0.001393396,0.0024995985,0.0017857143,0.0029651949,0.0026597816],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006340475,0.0002906629,0.012793602,0.00092103647,0.0007614939,0.0006593418,0.0003678492,0.88490087,0.0019155114,0.07598571,0.0052673053,0.015502665],"study_design_scores_gemma":[0.00020885978,0.00023942169,0.0018967581,0.00013748648,0.00040529942,0.00022016022,0.00008076103,0.9771398,0.00027106577,0.01683264,0.0025154273,0.00005243746],"about_ca_topic_score_codex":0.014335784,"about_ca_topic_score_gemma":0.00582063,"teacher_disagreement_score":0.016624361,"about_ca_system_score_codex":0.0026221443,"about_ca_system_score_gemma":0.0026162895,"threshold_uncertainty_score":0.055614054},"labels":[],"label_agreement":null},{"id":"W4404075406","doi":"10.1002/psp4.13256","title":"Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Probabilistic and Robust Engineering Design","field":"Decision Sciences","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Bayer","keywords":"Physiologically based pharmacokinetic modelling; Sobol sequence; Sensitivity (control systems); Parametric statistics; Computer science; Suite; Pharmacokinetics; Parametric model; Pharmacology; Mathematics; Statistics; Engineering; Medicine","score_opus":0.17897910999179253,"score_gpt":0.4432367166416438,"score_spread":0.2642576066498513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404075406","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09120063,0.0009866656,0.8845608,0.0005991299,0.00008540495,0.000326183,0.002205313,0.0020059145,0.018029839],"genre_scores_gemma":[0.87977177,0.0008017149,0.11082459,0.00022560116,0.000045200202,0.00079775613,0.0021558004,0.000496915,0.0048806476],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99560237,0.0026921565,0.00014333964,0.00035043008,0.0010093012,0.0002023747],"domain_scores_gemma":[0.98729485,0.010575453,0.00051982905,0.0005228973,0.0009804111,0.00010650744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008265858,0.0014334325,0.0012332499,0.0017658485,0.00045934485,0.0017369168,0.0011258916,0.0010148654,0.0053942525],"category_scores_gemma":[0.014826319,0.000568425,0.0022130103,0.0009888286,0.0006689187,0.000997474,0.001723275,0.0015126625,0.00049487205],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003879853,0.000023650098,0.00065922947,0.00010504947,0.00008773178,0.000061486135,0.000025522031,0.97998637,0.0007556893,0.008676361,0.00085934077,0.0087206755],"study_design_scores_gemma":[0.000008849604,0.00006013628,0.00042470402,0.00002424485,0.00003457376,0.0000284447,0.000016808111,0.9875994,0.0013079584,0.008713587,0.0017640406,0.00001735569],"about_ca_topic_score_codex":0.007534302,"about_ca_topic_score_gemma":0.00427971,"teacher_disagreement_score":0.008265858,"about_ca_system_score_codex":0.0017143632,"about_ca_system_score_gemma":0.001807603,"threshold_uncertainty_score":0.043714523},"labels":[],"label_agreement":null},{"id":"W4404610816","doi":"10.1002/psp4.13280","title":"Clinical study design strategies to mitigate confounding effects of time‐dependent clearance on dose optimization of therapeutic antibodies","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia; Killam Trusts","keywords":"Confounding; Medicine; Sample size determination; Population; Clinical trial; Internal medicine; Statistics; Mathematics","score_opus":0.06467598173167563,"score_gpt":0.42622265070390564,"score_spread":0.36154666897223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404610816","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.084073335,0.0022491508,0.79771394,0.0040104534,0.00084920204,0.09791051,0.001402345,0.0011966871,0.010594369],"genre_scores_gemma":[0.39160147,0.0008443175,0.47556663,0.002821184,0.00018486554,0.12646805,0.00042162745,0.00009873788,0.001993149],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.84661657,0.14307046,0.003987253,0.0023964061,0.0032345685,0.00069484103],"domain_scores_gemma":[0.8302186,0.1292178,0.015938282,0.014866924,0.0077037537,0.0020546133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15398534,0.0015352315,0.0014651805,0.0011233921,0.00063520303,0.0020018134,0.0018493007,0.0029811745,0.0066704447],"category_scores_gemma":[0.21304326,0.0015083855,0.0020827348,0.0008356399,0.001373274,0.0017860697,0.0020089804,0.002643475,0.0013515552],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10394122,0.0066747414,0.03700192,0.007782695,0.008924477,0.0013027376,0.0021522176,0.26193658,0.020928515,0.11668193,0.0154548865,0.41721815],"study_design_scores_gemma":[0.0950933,0.07342308,0.021167295,0.003047876,0.008505541,0.0012002074,0.00047218788,0.44111443,0.0350923,0.19548963,0.12491189,0.00048229462],"about_ca_topic_score_codex":0.0004317305,"about_ca_topic_score_gemma":0.00060689246,"teacher_disagreement_score":0.15398534,"about_ca_system_score_codex":0.0011705646,"about_ca_system_score_gemma":0.0048168837,"threshold_uncertainty_score":0.81436205},"labels":[],"label_agreement":null},{"id":"W4405368987","doi":"10.1002/psp4.13287","title":"Clinical modeling of motor function to predict treatment efficacy and enable in silico treatment comparisons in infantile‐onset Pompe disease","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Clinical trial; Medicine; Disease; Confounding; Biomarker; Physical medicine and rehabilitation; Randomized controlled trial; Comet; Internal medicine; Physical therapy; Biology","score_opus":0.08787990650333857,"score_gpt":0.4296761385240595,"score_spread":0.34179623202072096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405368987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74678457,0.0035348828,0.22010739,0.003642971,0.00024366152,0.0012066681,0.006368371,0.00046206912,0.0176495],"genre_scores_gemma":[0.9789489,0.000835454,0.01436079,0.0005538994,0.000031648426,0.0009977228,0.0012234426,0.000028266895,0.0030200018],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99941015,0.00032805098,0.000036851186,0.00009868842,0.00005320699,0.00007301749],"domain_scores_gemma":[0.9967554,0.0025251445,0.0003623643,0.00008630764,0.00016662528,0.00010414373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020066279,0.0008977075,0.0013567416,0.00045535062,0.00022891424,0.0010133494,0.0011236153,0.0016202551,0.0028315925],"category_scores_gemma":[0.006704324,0.00070981175,0.0017474772,0.00035536496,0.00060037983,0.0004651073,0.0005899984,0.0011328548,0.0003593022],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029144363,0.000089989495,0.0031949612,0.00010999152,0.000108073626,0.000088839275,0.000032212913,0.990337,0.001002578,0.0017515151,0.0003745449,0.0026187978],"study_design_scores_gemma":[0.00025391325,0.00042212888,0.001844687,0.0000308121,0.00013834808,0.000052189996,0.00002246345,0.9931172,0.0005286238,0.0025414655,0.0010294712,0.000018597031],"about_ca_topic_score_codex":0.01281553,"about_ca_topic_score_gemma":0.0073641283,"teacher_disagreement_score":0.01281553,"about_ca_system_score_codex":0.0014975643,"about_ca_system_score_gemma":0.0018596648,"threshold_uncertainty_score":0.02548188},"labels":[],"label_agreement":null},{"id":"W4408504822","doi":"10.1002/psp4.70017","title":"Comparison of Model‐Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged &lt; 5 Years With Homozygous Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Dosing; Pharmacokinetics; Population; Lipoprotein; Gastroenterology; Body weight; Internal medicine; Pediatrics; Cholesterol","score_opus":0.03740819570575227,"score_gpt":0.3463627957102121,"score_spread":0.30895460000445985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408504822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953967,0.00014059231,0.0035925482,0.00003820232,0.000003067847,0.000010955947,0.00044089754,0.00006624228,0.0003108934],"genre_scores_gemma":[0.9979152,0.00008002597,0.001087379,0.000017946588,0.0000022121328,0.000014136111,0.0007392372,0.000008728478,0.00013503205],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999835,0.00006249478,0.0000084194,0.000047168087,0.000017519113,0.000029268902],"domain_scores_gemma":[0.999281,0.00046232942,0.00012822701,0.000046033572,0.000046446592,0.000036068886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000804248,0.00038146952,0.00048574142,0.00022607303,0.00009727733,0.0003897283,0.0003192325,0.00034184667,0.00054211495],"category_scores_gemma":[0.0016574875,0.00019739101,0.0006707432,0.00017969032,0.00014786357,0.00022824625,0.00019236172,0.00040804135,0.00017000381],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028416815,0.00030463524,0.5271033,0.00006797967,0.0007569875,0.00041077624,0.00016102553,0.4420533,0.0045044697,0.0007192543,0.0010695637,0.020006863],"study_design_scores_gemma":[0.00017443717,0.0013628984,0.1891392,0.000014109569,0.00038123006,0.00068572746,0.00009919822,0.8020045,0.0039303973,0.0005734212,0.0015880656,0.000046808884],"about_ca_topic_score_codex":0.011780162,"about_ca_topic_score_gemma":0.0046539367,"teacher_disagreement_score":0.011780162,"about_ca_system_score_codex":0.0005961401,"about_ca_system_score_gemma":0.00056634593,"threshold_uncertainty_score":0.023423195},"labels":[],"label_agreement":null},{"id":"W4409148862","doi":"10.1002/psp4.70028","title":"Harnessing Open‐Source Solutions: Insights From the First Open Systems Pharmacology (<scp>OSP</scp>) Community Conference","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; European Commission; Vlaamse regering; National Institute of Child Health and Human Development; Fonds Wetenschappelijk Onderzoek","keywords":"Open source; Context (archaeology); Open source software; Engineering; Library science; Engineering management; Pharmacology; Computer science; Medicine; Software; Biology","score_opus":0.11820851000632661,"score_gpt":0.3964888850400766,"score_spread":0.27828037503375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409148862","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.093842246,0.09520209,0.11712569,0.5233609,0.0021667758,0.00026615663,0.0010492977,0.00061598583,0.16637085],"genre_scores_gemma":[0.7835423,0.11904686,0.060480084,0.022225834,0.00364251,0.00035551548,0.0010190514,0.00059968786,0.00908819],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.9833777,0.011008418,0.00040309707,0.0006185256,0.0034824202,0.001109851],"domain_scores_gemma":[0.9138033,0.07146591,0.0027451715,0.00290961,0.0053309444,0.003745137],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.030801278,0.0006714211,0.0005471934,0.003572705,0.0024730111,0.012517925,0.0011242293,0.0027375552,0.0033035055],"category_scores_gemma":[0.06206285,0.00035701948,0.00070585177,0.00573602,0.0068824864,0.010822552,0.008325327,0.0050425758,0.00060727523],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012163542,0.0002132723,0.008590335,0.001244401,0.00009313437,0.0004738937,0.010205007,0.0031215975,0.0008676497,0.678222,0.05741933,0.23942776],"study_design_scores_gemma":[0.000044302553,0.00016278993,0.009109412,0.0027041244,0.000058916394,0.000322384,0.0120385345,0.006403761,0.001560999,0.520719,0.44678515,0.00009062871],"about_ca_topic_score_codex":0.0029441772,"about_ca_topic_score_gemma":0.00463014,"teacher_disagreement_score":0.9988758,"about_ca_system_score_codex":0.0052279863,"about_ca_system_score_gemma":0.009240431,"threshold_uncertainty_score":0.16289467},"labels":[],"label_agreement":null},{"id":"W4410241330","doi":"10.1002/psp4.70033","title":"Virtual Clinical Trial Reveals Significant Clinical Potential of Targeting Tumor‐Associated Macrophages and Microglia to Treat Glioblastoma","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fonds de Recherche du Québec - Santé; Université de Montréal; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Microglia; Nivolumab; CD8; Medicine; Glioblastoma; CD47; Clinical trial; Cancer research; Immune system; Tumor microenvironment; Immunotherapy; Oncology; Immunology; Internal medicine; Inflammation","score_opus":0.029323852242914863,"score_gpt":0.37808100198340033,"score_spread":0.3487571497404855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410241330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96223027,0.0059819864,0.016987571,0.0034771252,0.00058221613,0.00036812443,0.0009592885,0.00058878143,0.0088244565],"genre_scores_gemma":[0.9943203,0.00092266157,0.0024516964,0.00038688153,0.000044282708,0.00019082127,0.0003354477,0.000017572967,0.0013302808],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998766,0.00006128746,0.0000044363214,0.000019138966,0.000014858321,0.000023678203],"domain_scores_gemma":[0.9998159,0.00007528257,0.000033199678,0.000014366095,0.0000134599,0.000047778365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062199007,0.00045128074,0.0006336729,0.00016029527,0.000120716264,0.000611421,0.00032102893,0.00044357838,0.0029665807],"category_scores_gemma":[0.0007849924,0.00010528309,0.000527161,0.00010685129,0.00029090402,0.0003819684,0.0002671273,0.0005961893,0.00023605522],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08354799,0.010876066,0.008654278,0.0024297193,0.0012549671,0.0007261599,0.00012595094,0.360952,0.08379014,0.021348564,0.023555646,0.40273857],"study_design_scores_gemma":[0.026127927,0.11007073,0.009089959,0.00020281802,0.0016457239,0.0007115425,0.00012370358,0.77506435,0.031376746,0.020152807,0.025304945,0.00012881955],"about_ca_topic_score_codex":0.00089365756,"about_ca_topic_score_gemma":0.001281651,"teacher_disagreement_score":0.0029665807,"about_ca_system_score_codex":0.00048189238,"about_ca_system_score_gemma":0.00097027596,"threshold_uncertainty_score":0.009924233},"labels":[],"label_agreement":null},{"id":"W4412512208","doi":"10.1002/psp4.70081","title":"Integrated Modeling of Digital‐Motor and Clinician‐Reported Outcomes Using Item Response Theory: Towards Powerful Trials for Rare Neurological Diseases","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke","funders":"Else Kröner-Fresenius-Stiftung; ZonMw; Ministero della Salute; Deutsche Forschungsgemeinschaft; European Commission","keywords":"Physical medicine and rehabilitation; Item response theory; Psychology; Medicine; Neuroscience; Computer science; Clinical psychology; Psychometrics","score_opus":0.2257825793792282,"score_gpt":0.44570045099671457,"score_spread":0.21991787161748638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412512208","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0103218,0.0009285297,0.98420334,0.0017257364,0.00010433952,0.000997525,0.00041278952,0.0004950001,0.00081102265],"genre_scores_gemma":[0.29569614,0.000899436,0.6916446,0.0022414827,0.00026436598,0.0064079063,0.0012003161,0.00023964781,0.0014061276],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.7240184,0.2608364,0.0037710418,0.005478515,0.0047680577,0.0011275803],"domain_scores_gemma":[0.6437093,0.32558525,0.0094503155,0.013040285,0.0067240894,0.0014907456],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21994188,0.0027790386,0.0051293788,0.0028790298,0.0007243217,0.005421317,0.00492117,0.004832842,0.004219806],"category_scores_gemma":[0.31454206,0.0024296746,0.007916847,0.0027877262,0.004026241,0.0050450815,0.0053076944,0.00745095,0.0013645166],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002818305,0.0006696654,0.025548104,0.001966652,0.0075518563,0.0006454084,0.001288012,0.7198312,0.00104797,0.11870186,0.0032910982,0.116639815],"study_design_scores_gemma":[0.00072323676,0.0012629982,0.0024492254,0.00040154194,0.0008539803,0.00012863263,0.00011579494,0.8317133,0.00050591794,0.15754597,0.004166603,0.00013284947],"about_ca_topic_score_codex":0.0049946243,"about_ca_topic_score_gemma":0.0033040848,"teacher_disagreement_score":0.78005815,"about_ca_system_score_codex":0.002823151,"about_ca_system_score_gemma":0.0056766113,"threshold_uncertainty_score":0.96195054},"labels":[],"label_agreement":null},{"id":"W4412984454","doi":"10.1002/psp4.70082","title":"A Pharmacometrics‐Informed Trial Simulation Framework for Optimizing Study Designs for Disease‐Modifying Treatments in Rare Neurological Disorders","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"HORIZON EUROPE Framework Programme; Eberhard Karls Universität Tübingen; European Commission; European Federation of Pharmaceutical Industries and Associations","keywords":"Analysis of covariance; Clinical trial; Population; Randomized controlled trial; Clinical study design; Disease; Randomization; Sample size determination; Computer science; Causal inference; Resampling; Research design; Machine learning; Medicine; Artificial intelligence; Statistics; Mathematics; Surgery; Pathology","score_opus":0.1851698973901009,"score_gpt":0.4608491044763785,"score_spread":0.2756792070862776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412984454","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012166994,0.0011315604,0.9767412,0.0028245677,0.00010371585,0.0015875882,0.00083391776,0.00028944793,0.0043210676],"genre_scores_gemma":[0.45265195,0.0022316156,0.53153414,0.0016992786,0.00027857683,0.0068079713,0.0012481406,0.00012272481,0.0034255588],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9683108,0.028479919,0.0006450576,0.0010302626,0.0010761602,0.00045787348],"domain_scores_gemma":[0.9223648,0.06912272,0.0034164195,0.0019068773,0.0020781534,0.001111099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0481062,0.0018230486,0.0032769986,0.0023715284,0.0006297871,0.0026252635,0.0027571635,0.0028854143,0.006780902],"category_scores_gemma":[0.08755369,0.0012651923,0.0022715502,0.0018638852,0.0021542984,0.0023849776,0.00265673,0.0030249055,0.00059902295],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041097097,0.000091658134,0.0016976312,0.0003409848,0.0002889546,0.00011241462,0.00007691055,0.8771359,0.00020523314,0.0993078,0.0011359219,0.019195683],"study_design_scores_gemma":[0.00042696245,0.00020384813,0.00036225273,0.00010286742,0.00015859863,0.000042654297,0.00002036337,0.8714658,0.0002020522,0.12452083,0.0024669918,0.000026809143],"about_ca_topic_score_codex":0.005075537,"about_ca_topic_score_gemma":0.00379779,"teacher_disagreement_score":0.0481062,"about_ca_system_score_codex":0.0032524092,"about_ca_system_score_gemma":0.008993598,"threshold_uncertainty_score":0.254413},"labels":[],"label_agreement":null},{"id":"W4414476131","doi":"10.1002/psp4.70115","title":"An Open‐Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Waterloo","funders":"Food and Drug Administration; U.S. Food and Drug Administration; U.S. Department of Health and Human Services","keywords":"Bioequivalence; Physiologically based pharmacokinetic modelling; In silico; IVIVC; Toolbox; Rework; Inference; In vivo; Benchmark (surveying); Repurposing","score_opus":0.7654397942060153,"score_gpt":0.6792413634340045,"score_spread":0.08619843077201073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414476131","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030457144,0.0004889182,0.9696581,0.00046049917,0.00013637434,0.00029709443,0.002014923,0.024477981,0.0021615925],"genre_scores_gemma":[0.019499457,0.0014561305,0.9583592,0.0008810653,0.00017521031,0.0032126473,0.0053615095,0.007949862,0.0031049603],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9942253,0.0030269744,0.00056599104,0.0005236248,0.0014503428,0.00020785854],"domain_scores_gemma":[0.9772893,0.016987104,0.0011435485,0.0022453011,0.0017028003,0.0006318419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02014739,0.0020081564,0.0018689487,0.0021173037,0.00058837124,0.0038923023,0.004965943,0.0026336499,0.037743036],"category_scores_gemma":[0.043127388,0.0019953288,0.0036434587,0.0015603519,0.0013344275,0.002019156,0.004792123,0.0042304765,0.013988959],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007303872,0.00033873596,0.0020682635,0.0036004137,0.0016954534,0.00087271834,0.00044041473,0.26397252,0.004539643,0.2320723,0.1278929,0.3617763],"study_design_scores_gemma":[0.0007896444,0.00019910783,0.0005645713,0.00073886546,0.00029120402,0.0004213674,0.000046790254,0.47511062,0.003021424,0.25483483,0.26386663,0.0001150051],"about_ca_topic_score_codex":0.003110349,"about_ca_topic_score_gemma":0.003923008,"teacher_disagreement_score":0.037743036,"about_ca_system_score_codex":0.0013753964,"about_ca_system_score_gemma":0.0057368795,"threshold_uncertainty_score":0.12626302},"labels":[],"label_agreement":null},{"id":"W4414478367","doi":"10.1002/psp4.70120","title":"Model‐Informed Drug Development of Subcutaneous Nivolumab: Comparison of Pharmacokinetic Analysis Methodologies Using Clinical Trial Simulation","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"NONMEM; Pharmacokinetics; Population; Clinical trial; Population pharmacokinetics; Drug development; Pooled analysis; Drug","score_opus":0.3510040612031019,"score_gpt":0.5559946688922948,"score_spread":0.20499060768919286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414478367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6873696,0.0013470413,0.30102247,0.0010304266,0.00006912716,0.0009209211,0.00090702187,0.0005651303,0.006768309],"genre_scores_gemma":[0.9573558,0.00029398888,0.040820632,0.00013940978,0.00001387063,0.00047361455,0.00027458835,0.000028295492,0.00059985224],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983261,0.0013630637,0.000054149095,0.00008355003,0.00012615004,0.00004696674],"domain_scores_gemma":[0.9833452,0.014472941,0.00074456667,0.0004771149,0.0008065616,0.0001534968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006202897,0.0006492971,0.00087786507,0.0005448023,0.00019167495,0.00086651585,0.0009446353,0.0008139779,0.0010900924],"category_scores_gemma":[0.01290727,0.0005298132,0.0007925141,0.00030456044,0.00030476376,0.0005083108,0.0005056787,0.0009902654,0.00011170463],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037212612,0.00008556199,0.0013742844,0.000052567928,0.00006809578,0.000020590256,0.00001994774,0.9914922,0.00034835425,0.0010818216,0.00012578703,0.0049586166],"study_design_scores_gemma":[0.00006285266,0.00012024658,0.00023560545,0.00000692296,0.00001816886,0.000006776373,0.000004325124,0.9986759,0.00024451848,0.0004992062,0.00012102683,0.0000044640437],"about_ca_topic_score_codex":0.008870391,"about_ca_topic_score_gemma":0.0047805686,"teacher_disagreement_score":0.008870391,"about_ca_system_score_codex":0.0011907468,"about_ca_system_score_gemma":0.002569356,"threshold_uncertainty_score":0.03280443},"labels":[],"label_agreement":null},{"id":"W4414743051","doi":"10.1002/psp4.70121","title":"Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Sanofi","keywords":"Dosing; Regimen; Pharmacokinetics; Pharmacodynamics; Population; Atopic dermatitis; Phases of clinical research","score_opus":0.025567964184274865,"score_gpt":0.3532375779191448,"score_spread":0.3276696137348699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414743051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54645205,0.002870562,0.42536718,0.0013872649,0.00009050927,0.000728573,0.0041784286,0.0011938624,0.017731717],"genre_scores_gemma":[0.96752685,0.00081544457,0.025628742,0.00034499165,0.000028306109,0.00052566075,0.00091774756,0.000091120884,0.004121155],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996008,0.00019656583,0.000015244233,0.00007307273,0.00007072106,0.000043654993],"domain_scores_gemma":[0.99919766,0.00056239526,0.00010812579,0.000023687162,0.00008064876,0.000027527109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013977927,0.00060875935,0.000875854,0.00047397247,0.00023184154,0.0012081348,0.00071821385,0.0010141332,0.0014738489],"category_scores_gemma":[0.0026938731,0.00061419146,0.0013536324,0.0003722248,0.00021295638,0.00041017836,0.00042892972,0.0011870351,0.00041691834],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019263987,0.00007261107,0.0031965633,0.00004409417,0.00010502964,0.0001149623,0.000031968415,0.98668784,0.0011735138,0.0010553016,0.00063425396,0.0066911466],"study_design_scores_gemma":[0.000030515566,0.00010535609,0.0011218735,0.000009511229,0.000050877494,0.00004923453,0.0000079138035,0.99619114,0.00033207188,0.0009255496,0.0011651296,0.0000108101],"about_ca_topic_score_codex":0.012983481,"about_ca_topic_score_gemma":0.0068095215,"teacher_disagreement_score":0.012983481,"about_ca_system_score_codex":0.0010917198,"about_ca_system_score_gemma":0.0016513239,"threshold_uncertainty_score":0.025815785},"labels":[],"label_agreement":null},{"id":"W4416333858","doi":"10.1002/psp4.70131","title":"The Impact of <scp>QSP</scp> Modeling on the Design and Optimization of Gene Therapy Approaches","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Genome editing; Biodistribution; Systems pharmacology; Genetic enhancement; Translation (biology); Systems biology; Genome; Biomedicine","score_opus":0.07335593318135632,"score_gpt":0.32528171797899813,"score_spread":0.2519257847976418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416333858","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01836519,0.0013399074,0.96267295,0.0022126106,0.0000834837,0.000128025,0.0003267204,0.00054613187,0.014324992],"genre_scores_gemma":[0.7224477,0.0051453947,0.26480773,0.0011032069,0.00014013241,0.0007048021,0.00048542378,0.00056723703,0.004598454],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979074,0.0012014196,0.0000761353,0.00019230359,0.00054754486,0.00007515986],"domain_scores_gemma":[0.99506515,0.0039834096,0.00027770875,0.00028674834,0.0003307943,0.000056173845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055898004,0.0009553127,0.0011302081,0.00055507396,0.00036497816,0.0020063948,0.00092734693,0.00083522045,0.0014493791],"category_scores_gemma":[0.008347651,0.00054659287,0.00081021513,0.0005728403,0.0013767135,0.0015944502,0.00092781754,0.0015362274,0.00051315053],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050263658,0.00005346091,0.00076741265,0.0002744563,0.00004913092,0.00005327001,0.000053618427,0.8927058,0.0066662016,0.07371094,0.0009744009,0.024641084],"study_design_scores_gemma":[0.00001043561,0.000060786755,0.00016202213,0.000033665652,0.000013086516,0.000021747564,0.000016354232,0.9686076,0.0031285463,0.023748288,0.004183195,0.000014299146],"about_ca_topic_score_codex":0.0043927305,"about_ca_topic_score_gemma":0.0022725847,"teacher_disagreement_score":0.0055898004,"about_ca_system_score_codex":0.0020988719,"about_ca_system_score_gemma":0.0024325717,"threshold_uncertainty_score":0.029562056},"labels":[],"label_agreement":null}]}